Tables
TABLE 1 FUNDING SCENARIO 19
TABLE 2 GLOBAL POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCTS, 2018-2025 ($MILLION) 33
TABLE 3 GLOBAL INFECTIOUS DISEASE POINT-OF-CARE DIAGNOSTICS MARKET, BY TYPE, 2018-2025 ($MILLION) 36
TABLE 4 GLOBAL POINT-OF-CARE DIAGNOSTICS MARKET, BY PRESCRIPTION MODE, 2018-2025 ($MILLION) 57
TABLE 5 GLOBAL POINT-OF-CARE DIAGNOSTICS MARKET REVENUE BY REGIONS, 2018-2025 ($MILLION) 64
TABLE 6 EUROPEAN POINT-OF-CARE DIAGNOSTICS MARKET, BY COUNTRY, 2018-2025 ($MILLION) 67
TABLE 7 GLOBAL POINT-OF-CARE DIAGNOSTICS MARKET BY VENDOR RANKING, 2018 79
TABLE 8 OTHER PROMINENT VENDORS OF POINT-OF-CARE DIAGNOSTICS MARKET 79
TABLE 9 ABBOTT LABORATORIES: PRODUCT OFFERINGS 81
TABLE 10 ABBOTT LABORATORIES: RECENT DEVELOPMENTS 82
TABLE 11 F. HOFFMANN-LA ROCHE: PRODUCT OFFERINGS 90
TABLE 12 F. HOFFMANN-LA ROCHE: RECENT DEVELOPMENTS 91
TABLE 13 JOHNSON & JOHNSON: PRODUCT OFFERINGS 98
TABLE 14 JOHNSON & JOHNSON: RECENT DEVELOPMENTS 98
TABLE 15 DANAHER CORPORATION: PRODUCT OFFERINGS 106
TABLE 16 DANAHER CORPORATION: RECENT DEVELOPMENTS 109
TABLE 17 SIEMENS HEALTHINEERS INC.: PRODUCT OFFERINGS 116
TABLE 18 SIEMENS HEALTHINEERS INC.: RECENT DEVELOPMENTS 117
TABLE 19 TRINITY BIOTECH PLC: SNAPSHOT 124
TABLE 20 TRINITY BIOTECH PLC: RECENT DEVELOPMENTS 125
TABLE 21 QIAGEN N.V.: SNAPSHOT 125
TABLE 22 QIAGEN N.V.: RECENT DEVELOPMENTS 126
TABLE 23 BIOMERIEUX S.A.: SNAPSHOT 131
TABLE 24 BIOMERIEUX S.A.: RECENT DEVELOPMENTS 132
TABLE 25 ORASURE TECHNOLOGIES: SNAPSHOT 133
TABLE 26 ORASURES TECHNOLOGIES: RECENT DEVELOPMENTS 134
TABLE 27 INSTRUMENTATION LABORATORY: SNAPSHOT 134
TABLE 28 INSTRUMENTATION LABORATORY: RECENT DEVELOPMENTS 135
TABLE 29 BECTON DICKINSON AND COMPANY: SNAPSHOT 136
TABLE 30 BECTON DICKINSON AND COMPANY: RECENT DEVELOPMENTS 137
TABLE 31 NOVA BIOMEDICAL: SNAPSHOT 139
TABLE 32 NOVA BIOMEDICAL: RECENT DEVELOPMENTS 139
LIST OF FIGURE
Charts
CHART 1 RESEARCH METHODOLOGY OF GLOBAL POINT-OF-CARE DIAGNOSTICS MARKET 13
CHART 2 GLOBAL POINT-OF-CARE DIAGNOSTICS MARKET REVENUE, 2019–2025 ($MILLION) 17
CHART 3 SEGMENTATION OF GLOBAL POINT-OF-CARE DIAGNOSTICS MARKET 21
CHART 4 PEST ANALYSIS OF GLOBAL POINT-OF-CARE DIAGNOSTICS MARKET 21
CHART 5 PORTER 5 FORCES ON GLOBAL POINT-OF-CARE DIAGNOSTICS MARKET 23
CHART 6 DRO – IMPACT ANALYSIS OF GLOBAL POINT-OF-CARE DIAGNOSTICS MARKET 29
CHART 7 KEY STAKEHOLDERS 31
CHART 8 GLOBAL POINT-OF-CARE DIAGNOSTICS MARKET BY PRODUCT, 2018 V/S 2025 ($) 32
CHART 9 GLOBAL GLUCOSE MONITORING MARKET REVENUE FORECAST, 2019–2025 ($MILLION) 34
CHART 10 GLOBAL INFECTIOUS DISEASE TESTING MARKET REVENUE FORECAST, 2019–2025 ($MILLION) 35
CHART 11 GLOBAL INFLUENZA TESTING MARKET REVENUE FORECAST, 2019–2025 ($MILLION) 37
CHART 12 GLOBAL HIV TESTING MARKET REVENUE FORECAST, 2019–2025 ($MILLION) 39
CHART 13 GLOBAL HEPATITIS TESTING MARKET REVENUE FORECAST, 2019–2025 ($MILLION) 40
CHART 14 GLOBAL TUBERCULOSIS TESTING MARKET REVENUE FORECAST, 2019–2025 ($MILLION) 41
CHART 15 GLOBAL SEXUALLY TRANSMITTED DISEASE TESTING MARKET REVENUE FORECAST, 2019–2025 ($MILLION) 42
CHART 16 GLOBAL HEALTHCARE-ASSOCIATED INFECTIONS TESTING MARKET REVENUE FORECAST, 2019–2025 ($MILLION) 43
CHART 17 GLOBAL RESPIRATORY INFECTIONS TESTING MARKET REVENUE FORECAST, 2019–2025 ($MILLION) 44
CHART 18 GLOBAL OTHERS MARKET REVENUE FORECAST, 2019–2025 ($MILLION) 45
CHART 19 GLOBAL PREGNANCY AND FERTILITY TESTING MARKET REVENUE FORECAST, 2019–2025 ($MILLION) 46
CHART 20 GLOBAL HEMATOLOGY TESTING MARKET REVENUE FORECAST, 2019–2025 ($MILLION) 47
CHART 21 GLOBAL CARDIOMETABOLIC MONITORING MARKET REVENUE FORECAST, 2019–2025 ($MILLION) 48
CHART 22 GLOBAL URINALYSIS TESTING MARKET REVENUE FORECAST, 2019–2025 ($MILLION) 49
CHART 23 GLOBAL COAGULATION MONITORING MARKET REVENUE FORECAST, 2019–2025 ($MILLION) 51
CHART 24 GLOBAL TUMOUR OR CANCER MARKER TESTING MARKET REVENUE FORECAST, 2019–2025 ($MILLION) 52
CHART 25 GLOBAL CHOLESTEROL TESTING MARKET REVENUE FORECAST, 2019–2025 ($MILLION) 53
CHART 26 GLOBAL DRUGS OF ABUSE TESTING MARKET REVENUE FORECAST, 2019–2025 ($MILLION) 54
CHART 27 GLOBAL OTHERS MARKET REVENUE FORECAST, 2019–2025 ($MILLION) 55
CHART 28 GLOBAL POINT-OF-CARE DIAGNOSTICS MARKET BY PRESCRIPTION MODE, 2018 V/S 2025 (%) 56
CHART 29 GLOBAL PRESCRIPTION-BASED POINT-OF-CARE DIAGNOSTICS MARKET REVENUE FORECAST, 2019–2025 ($MILLION) 57
CHART 30 GLOBAL OTC-BASED POINT-OF-CARE DIAGNOSTICS MARKET REVENUE FORECAST, 2019–2025 ($MILLION) 59
CHART 31 GLOBAL POINT-OF-CARE DIAGNOSTICS MARKET BY END-USERS SEGMENTATION, 2018 (%) 60
CHART 32 GLOBAL POINT-OF-CARE DIAGNOSTICS MARKET BY GEOGRAPHICAL SEGMENTATION, 2018 V/S 2025 (%) 63
CHART 33 POINT-OF-CARE DIAGNOSTICS MARKET REVENUE IN NORTH AMERICA, 2019–2025 ($MILLION) 64
CHART 34 POINT-OF-CARE DIAGNOSTICS MARKET REVENUE IN EUROPE, 2019–2025 ($MILLION) 66
CHART 35 POINT-OF-CARE DIAGNOSTICS MARKET REVENUE IN UNITED KINGDOM, 2019–2025 ($MILLION) 68
CHART 36 POINT-OF-CARE DIAGNOSTICS MARKET REVENUE IN GERMANY, 2019–2025 ($MILLION) 69
CHART 37 POINT-OF-CARE DIAGNOSTICS MARKET REVENUE IN FRANCE, 2019–2025 ($MILLION) 70
CHART 38 POINT-OF-CARE DIAGNOSTICS MARKET REVENUE IN SPAIN, 2019–2025 ($MILLION) 71
CHART 39 POINT-OF-CARE DIAGNOSTICS MARKET REVENUE IN ITALY, 2019–2025 ($MILLION) 72
CHART 40 POINT-OF-CARE DIAGNOSTICS MARKET REVENUE IN OTHER EUROPEAN COUNTRIES, 2019–2025 ($MILLION) 72
CHART 41 POINT-OF-CARE DIAGNOSTICS REVENUE IN ASIA-PACIFIC, 2019–2025 ($MILLION) 73
CHART 42 POINT-OF-CARE DIAGNOSTICS MARKET REVENUE IN REST OF THE WORLD, 2019–2025 ($MILLION) 76
CHART 43 ABBOTT LABORATORIES.: OVERVIEW SNAPSHOT 86
CHART 44 ABBOTT LABORATORIES.: BUSINESS UNITS 87
CHART 45 ABBOTT LABORATORIES: GEOGRAPHIC PRESENCE 88
CHART 46 ABBOTT LABORATORIES.: SWOT ANALYSIS 88
CHART 51 JOHNSON & JOHNSON: OVERVIEW SNAPSHOT 100
CHART 52 JOHNSON & JOHNSON: BUSINESS UNITS 102
CHART 53 JOHNSON & JOHNSON: GEOGRAPHIC REVENUE 103
CHART 54 JOHNSON & JOHNSON: SWOT ANALYSIS 104
CHART 55 DANAHER CORPORATION: OVERVIEW SNAPSHOT 111
CHART 56 DANAHER CORPORATION: BUSINESS UNITS 112
CHART 57 DANAHER CORPORATION: GEOGRAPHIC PRESENCE 113
CHART 58 DANAHER CORPORATION: SWOT ANALYSIS 114
CHART 59 SIEMENS HEALTHINEERS, INC.: OVERVIEW SNAPSHOT 120
CHART 60 SIEMENS HEALTHINEERS, INC.: BUSINESS UNITS 121
CHART 61 SIEMENS HEALTHINEERS: GEOGRAPHIC PRESENCE 121
CHART 62 SIEMENS HEALTHINEERS INC.: SWOT ANALYSIS 122
